MedPath

University of Virginia

University of Virginia logo
🇺🇸United States
Ownership
Private
Established
1819-01-01
Employees
10K
Market Cap
-
Website
http://www.virginia.edu

Determining How Quickly Progesterone Slows LH Pulse Frequency

Phase 1
Completed
Conditions
PCOS
Normal
Interventions
First Posted Date
2008-01-15
Last Posted Date
2025-03-28
Lead Sponsor
University of Virginia
Target Recruit Count
85
Registration Number
NCT00594217
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

Phase 1
Conditions
Hypertension
Interventions
Drug: Placebo
First Posted Date
2008-01-11
Last Posted Date
2013-01-23
Lead Sponsor
University of Virginia
Target Recruit Count
44
Registration Number
NCT00592150
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced Ultrasonography

Not Applicable
Terminated
Conditions
Inflammatory Bowel Disease
Interventions
Other: Definity
First Posted Date
2008-01-11
Last Posted Date
2011-04-26
Lead Sponsor
University of Virginia
Target Recruit Count
10
Registration Number
NCT00591669
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Comprehensive Magnetic Resonance of Peripheral Arterial Disease

Not Applicable
Completed
Conditions
Peripheral Artery Disease
Interventions
Drug: Simvastatin/Ezetimibe
First Posted Date
2008-01-07
Last Posted Date
2017-08-21
Lead Sponsor
University of Virginia
Target Recruit Count
85
Registration Number
NCT00587678
Locations
🇺🇸

University of Virgina Health System, Charlottesville, Virginia, United States

Enhancing ADHD Driving Performance With Stimulant Medication

Not Applicable
Conditions
Attention Deficit Hyperactivity Disorder
Interventions
First Posted Date
2007-12-12
Last Posted Date
2009-09-03
Lead Sponsor
University of Virginia
Target Recruit Count
14
Registration Number
NCT00572026
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis

Phase 4
Terminated
Conditions
Spontaneous Bacterial Peritonitis
Interventions
Biological: human albumin
First Posted Date
2007-12-11
Last Posted Date
2014-12-03
Lead Sponsor
University of Virginia
Target Recruit Count
8
Registration Number
NCT00570960
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

A Prospective Study of the Effect of Topical Sodium Hyaluronate Immediately Post-PKP on Time to Reepithelialization

Not Applicable
Completed
Conditions
Corneal Transplantation
Interventions
First Posted Date
2007-12-11
Last Posted Date
2008-08-07
Lead Sponsor
University of Virginia
Target Recruit Count
50
Registration Number
NCT00570648
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Lovaza Therapy of Peripheral Arterial Disease

Not Applicable
Withdrawn
Conditions
Peripheral Artery Disease
Interventions
Drug: placebo
First Posted Date
2007-12-07
Last Posted Date
2018-05-07
Lead Sponsor
University of Virginia
Registration Number
NCT00569686
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

The Use of B-type Natriuretic Peptide (BNP) to Predict Closure of a Patent Ductus Arteriosus (PDA) in Premature Infants

Not Applicable
Completed
Conditions
Indomethacin Therapy
Patent Ductus Arteriosus
First Posted Date
2007-07-12
Last Posted Date
2018-05-07
Lead Sponsor
University of Virginia
Target Recruit Count
60
Registration Number
NCT00500305

Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults

Phase 1
Completed
Conditions
Aging
First Posted Date
2007-05-16
Last Posted Date
2007-05-16
Lead Sponsor
University of Virginia
Target Recruit Count
72
Registration Number
NCT00474279
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath